---
slug: anticoagulants-sickle-cell
title: Decreased Bleeding with Direct Oral Anticoagulants in Sickle Cell Disease
author: Hants Williams
author_url: https://github.com/hantswilliams
author_title: Healthcare Informatics Researcher
author_image_url: /img/hants.jpeg
date: 2019-05-15
tags: [sickle cell disease, anticoagulants, bleeding, venous thromboembolism]
---

# Decreased Bleeding Incidence With Direct Oral Anticoagulants Compared to Vitamin K Antagonist and Low-Molecular-Weight Heparin in Patients With Sickle Cell Disease and Venous Thromboembolism

## Abstract

This study compares bleeding incidents between direct oral anticoagulants and traditional anticoagulation methods in patients with sickle cell disease and venous thromboembolism.

<!--truncate-->

## Publication Information

Published in Acta Haematologica (2019)  
DOI: PMID: 31108496

## Overview

The research evaluates the safety and efficacy of direct oral anticoagulants compared to traditional anticoagulation methods in patients with sickle cell disease, focusing on bleeding incidents as a primary outcome.

[Full text available via Acta Haematologica]

## Citation

Patel, A., Williams, H., Baer, M. R., Zimrin, A. B., & Law, J. Y. (2019). Decreased Bleeding Incidence With Direct Oral Anticoagulants Compared to Vitamin K Antagonist and Low-Molecular-Weight Heparin in Patients With Sickle Cell Disease and Venous Thromboembolism. Acta Haematologica, 142(4), 233-238. PMID: 31108496
